Thank you for your interest. We will be in touch with further details shortly.
Oops! Something went wrong while submitting the form.
Angel investments are early stage equity investments made into start-up companies - generally either primary or secondary investment opportunities.
Many angel investors are often former entrepreneurs themselves and typically enjoy working with companies at the earliest stages of business formation.
SolasCure’s mission is to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients.
The business has the exclusive IP for their first product, Aurase – a hydrogel containing a safe, active, highly-specific enzyme cloned from medical maggots which improves the debridement of wounds and ulcers. Currently undergoing clinical trials to obtain medical authorisation in Europe and North America.
SolasCure has assembled a world-class team to drive the business forward to achieve healthy returns on investment. With initial investment backing by the Development Bank of Wales, they are now seeking additional private finance investment in order to reach CE Mark as a Class III medical device.
State: Registered: second phase investment required. No Revenue